Cutaneous manifestations associated with SARS-CoV-2 : an emerging topic in a pandemic era

© BMJ Publishing Group Limited 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ..

A 70-year-old man was admitted to our COVID-19 ward with thoracalgia, productive mucus cough, fatigue and erythematous-violaceous macules on the inner side of feet and interdigital regions. The patient was started on oxygen and dexamethasone. On the day of discharge, he maintained the skin changes despite the resolution of COVID-19 symptoms. A 57-year-old woman initially presented with diffuse urticarial rash on the cervical and chest region. Oral cetirizine was started, and pruritus improved. Thirty days after the discharge, the patient maintained the rash, but without pruritus. A 49-year-old man was admitted with thoracalgia, shortness of breath, dry cough and urticarial rash on the cervical and chest region. The patient was treated with cetirizine. The pruritus improved, and 5 days after discharge, the urticarial areas completely disappeared.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:14

Enthalten in:

BMJ case reports - 14(2021), 9 vom: 03. Sept.

Sprache:

Englisch

Beteiligte Personen:

Luís, Helena [VerfasserIn]
Barros, Carolina [VerfasserIn]
André, Diogo [VerfasserIn]
Malheiro, Alexandra [VerfasserIn]

Links:

Volltext

Themen:

COVID-19
Case Reports
Dermatology
Journal Article

Anmerkungen:

Date Completed 07.09.2021

Date Revised 31.05.2022

published: Electronic

Citation Status MEDLINE

doi:

10.1136/bcr-2021-244763

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM330223437